The 4 Period Moving Average forecasted value of Nanobac Pharmaceuticals Incorporated on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.00 and the sum of the absolute errors of 0.00. Nanobac Stock Forecast is based on your current time horizon. Although Nanobac Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Nanobac Pharmaceuticals' systematic risk associated with finding meaningful patterns of Nanobac Pharmaceuticals fundamentals over time.
Nanobac
As of 01/22/2025, Inventory Turnover is likely to drop to 1.54. In addition to that, Payables Turnover is likely to drop to 0.01. As of 01/22/2025, Net Loss is likely to drop to about (7.9 M).
A four-period moving average forecast model for Nanobac Pharmaceuticals Incorporated is based on an artificially constructed daily price series in which the value for a given day is replaced by the mean of that value and the values for four preceding and succeeding time periods. This model is best suited to forecast equities with high volatility.
Nanobac Pharmaceuticals 4 Period Moving Average Price Forecast For the 23rd of January
Given 90 days horizon, the 4 Period Moving Average forecasted value of Nanobac Pharmaceuticals Incorporated on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.00, mean absolute percentage error of 0.00, and the sum of the absolute errors of 0.00.
Please note that although there have been many attempts to predict Nanobac Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Nanobac Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
In the context of forecasting Nanobac Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Nanobac Pharmaceuticals' downside and upside margins for the forecasting period are 0.0001 and 0.0001, respectively. We have considered Nanobac Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
The below table displays some essential indicators generated by the model showing the 4 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Nanobac Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Nanobac Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AIC
Akaike Information Criteria
-9.223372036854776E14
Bias
Arithmetic mean of the errors
None
MAD
Mean absolute deviation
0.0
MAPE
Mean absolute percentage error
0.0
SAE
Sum of the absolute errors
0.0
The four period moving average method has an advantage over other forecasting models in that it does smooth out peaks and troughs in a set of daily price observations of Nanobac Pharmaceuticals. However, it also has several disadvantages. In particular this model does not produce an actual prediction equation for Nanobac Pharmaceuticals Incorporated and therefore, it cannot be a useful forecasting tool for medium or long range price predictions
Predictive Modules for Nanobac Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Nanobac Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Nanobac Pharmaceuticals. Your research has to be compared to or analyzed against Nanobac Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Nanobac Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Nanobac Pharmaceuticals.
Other Forecasting Options for Nanobac Pharmaceuticals
For every potential investor in Nanobac, whether a beginner or expert, Nanobac Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Nanobac Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Nanobac. Basic forecasting techniques help filter out the noise by identifying Nanobac Pharmaceuticals' price trends.
Nanobac Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Nanobac Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Nanobac Pharmaceuticals' current price.
Market strength indicators help investors to evaluate how Nanobac Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nanobac Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Nanobac Pharmaceuticals stock market strength indicators, traders can identify Nanobac Pharmaceuticals Incorporated entry and exit signals to maximize returns.
When running Nanobac Pharmaceuticals' price analysis, check to measure Nanobac Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobac Pharmaceuticals is operating at the current time. Most of Nanobac Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Nanobac Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobac Pharmaceuticals' price. Additionally, you may evaluate how the addition of Nanobac Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.